Philips EPIQ & Affiniti Series Abdominal Ultrasound Transducer C5-1 Used Patient Monitor

Philips EPIQ & Affiniti Series Abdominal Ultrasound Transducer C5-1 Used Patient Monitor

I. Product Positioning & Technical Specifications

1. Core Design Architecture

Curvilinear Broadband Array:
160-element curved array operating at 1.0–5.0 MHz (extendable to 1.2–3.0 MHz), delivering ≥20cm penetration depth while maintaining superficial tissue resolution.

Advanced Imaging Technologies:

PureWave Crystal Technology: Increases signal-to-noise ratio by 85% for enhanced imaging in obese patients.

Harmonic Imaging with SonoCT: Multi-angle compounding reduces artifacts and improves boundary delineation.

Frequency-Modulated Beamforming: Optimizes axial resolution (≤1.3mm at 4cm depth) for micro-lesion detection.

2. Multimodal Capabilities

Full Imaging Suite: 2D/M-mode/Color M-mode/PW Doppler/HPRF/Color Doppler/Power Angio/Real-time 3D fusion navigation.

Deep-Tissue Enhancement: Tissue-Specific Imaging (TSI) technology overcomes acoustic barriers in abdominal viscera (liver/kidneys) through gas and adipose layers.

II. Clinical Implementation

1. Diagnostic Applications

Primary Domains: Hepatobiliary system, pancreas, spleen, kidneys, urology (prostate/bladder), gynecology (uterus/ovaries), obstetrics (fetal anatomy screening).

Extended Use Cases:

Small organs (thyroid/breast)

Neonatal cephalic (non-transcranial)

MSK/peripheral vasculature

Challenging Examinations: Superior penetration for obese patients or retroperitoneal pathology versus standard probes.

2. Clinical Utility Metrics

Accuracy: 98.6% sensitivity for renal artery stenosis detection at velocities >150cm/s; clear visualization of portosystemic collaterals in cirrhosis.

Workflow Efficiency: Smart exam protocols reduce scan time by 30% in emergency/critical care settings.

III. System Integration & Compatibility

1. Supported Platforms

EPIQ Series: EPIQ 5/7 (requires native interface protocol)

Affiniti Series: Affiniti 50/70 (advanced features via software upgrade)

2. Synergistic Technologies

Fusion Navigation: Real-time CT/MRI overlay for interventional guidance (e.g., liver biopsy).

Quantitative Analysis: Shear Wave Elastography (liver fibrosis staging) and Micro-Flow Imaging (MFI) for tumor characterization.

IV. Procurement & Maintenance Protocol

1. Acquisition Guidelines

OEM-Restricted Procurement: Philips-proprietary interface limits supply to authorized distributors (e.g., Fujian Pengshang, Shanxi Xinzj).

Acceptance Criteria:

Lateral resolution: ≤1.8mm@4cm, ≤3.4mm@12cm

Curvature radius: 45R (ensures tissue contact integrity)

2. Operational Maintenance

Usage Compliance:

Contact only alcohol-based cleaners; organic solvents degrade lens integrity.

Power down host systems before disconnection; transport in OEM shock-proof cases.

Lifecycle Management: Recommended replacement at 48 months under high utilization. Cable failure constitutes 72% of field issues (replacement ≈60% of new unit cost).

V. Market Position & Evolution

Clinical Adoption: As Philips' premium abdominal transducer, C5-1 holds >70% penetration in tertiary hospitals. EPIQ 7 integration establishes it as obstetric gold standard.

Generational Advancements:

40% greater penetration vs. legacy C1-5; 30% harmonic sensitivity improvement.

Next-gen models (e.g., eL18-4) target specialized OB/GYN applications, while C5-1 remains the abdominal universal solution.

C5-1 Performance Benchmark

Conclusion

The C5-1 transducer establishes a diagnostic benchmark through adaptive multi-band penetration and advanced beamforming, particularly excelling in deep abdominal and technically challenging examinations. Note OEM procurement constraints and maintenance costs under intensive use. Despite emerging matrix array technologies, the C5-1 maintains indispensability in comprehensive abdominal ultrasound.